Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets
- January 2017
- 135 pages
- Report ID: 619256
Use this report to:
- Assess current market dynamics and estimate future demand for sample preparation in genomics, proteomics and epigenomics.
- Gain insight into existing products as well as new developments in genomics, proteomics and epigenomics, issues and factors impacting the global life sciences market.
- Identify major stakeholders, their product portfolio along with the most relevant patents.
- The global market for sample preparation in genomics, proteomics and epigenomics reached $5.2 billion in 2015. The market should reach $5.6 billion in 2016 and $7.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.5% from 2016 to 2021. - The instruments market for sample preparation in genomics, proteomics and epigenomics reached $1.8 billion in 2015. The market should reach $1.9 billion in 2016 and $2.6 billion by 2021, growing at a CAGR of 6.6% from 2016 to 2021.
- The consumables market for sample preparation in genomics, proteomics and epigenomics reached $1.6 billion in 2015. The market should reach over $1.7 billion in 2016 and $2.4 billion by 2021, growing at a CAGR of 7.1% from 2016 to 2021.
STUDY GOALS AND OBJECTIVES
BCC Research’s goal in preparing this study was to determine the global market and future demand for sample preparation in genomics, proteomics and epigenomics over the five-year period from 2016 to 2021. Our particular interest was in characterizing and quantifying the market for sample preparation in genomics, proteomics and epigenomics by product, end user, geographic region and application.
We also evaluate the market by segmenting it into instruments, consumables, accessories and sample preparation kits. Factors that impact the market for sample preparation have been discussed in detail. Key market dynamics in each regional market worldwide has been discussed in detail. Aspects that affect each subsegment, the drivers, restraints, threats and opportunities have been discussed. Our key objective was to present a comprehensive discussion of where the state-of-the-art is in sample preparation and forecast the future commercial potential for the key market segments.
This discussion will provide a basis for companies to make strategic choices in developing new products and markets, or deciding which segments to focus on to achieve the highest growth. The study will benefit sample preparation companies, pharmaceutical and biotechnology companies, laboratories and service providers, end users, governments around the world, healthcare agencies and others.
REASONS FOR DOING THE STUDY
The completion of the Human Genome Project in 2003 later served to have a major impact on the market for genomics, proteomics and epigenomics. The cost of sequencing has decreased significantly, and there has been rising interest in the fields of genomics and proteomics due to their increasing application in various other fields. Epigenomics is a part of genomics and has recently been applied successfully in cancer treatment. Downstream processing in genomics and proteomics requires a sample that is free of impurities in adequate quantities. Hence, sample preparation for these technologies is as important as downstream processing.
Widespread advancements in scientific research have been made due to the completion of the Human Genome Project. There has been a shift from cellular biology to molecular biology—from studying cell as a structure—to studying the structure and function of the macromolecules found within cells (e.g., proteins and nucleic acids). Genomics, the study of genes and their function, and proteomics, the study of proteins, are fields within the study of molecular biology.
Sample preparation refers to a range of activities that precede most forms of scientific analysis. Sample preparation is generally complex, laborious and one of the most error-prone steps within scientific research. It is nonetheless a universal activity among laboratories whose requirements drive a large and growing market, worldwide. The global market for sample preparation in genomics, proteomics and epigenomics is an interesting market as advances are occurring rapidly. The market is continually evolving to increase the speed and accuracy of sample preparation. Automation and miniaturization are shaping the industry. The market for sample preparation in genomics, proteomics and epigenomics is highly fragmented with many large and small companies such as U.S.-based Agilent Technologies Inc., Bio-Rad Laboratories and Danaher Corp.
SCOPE OF REPORT
This research report categorizes the market for sample preparation in genomics, proteomics and epigenomics by product segment. The major product segments are instruments, consumables, accessories and sample preparation kits. The instruments segment is subdivided into workstations, liquid handling systems, extraction systems and other instruments. Consumables are divided into columns, filters, tubes, plates and other consumables. Sample preparation kits are segmented into purification kits, isolation kits, extraction kits and others.
The global market for sample preparation is segmented by end user into research centers, academic institutes, and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies and others. The markets in North America, Europe, Asia and rest of the world are covered. The market is also segmented by application into genomics, proteomics and epigenomics.
- Sample preparation instrument manufacturers.
- Sample preparation consumables manufacturers.
- Sample preparation suppliers and distributors.
- Genomics, proteomics and epigenomics research laboratories.
- Genomics, proteomics and epigenomics companies.
- Consulting firms.
- Physicians and hospitals.
- Government agencies.
- Healthcare agencies.
This research study used extensive secondary sources such as directories, databases, white papers, as well as annual reports, SEC filings and other company documents. Secondary research was mainly used to identify and collect information for the extensive technical, market-oriented and commercial study of this global market. It was also used to obtain key information about major market participants, market classification and segmentation according to industry trends, geographic markets and important developments. During the course of this study, a database of key industry leaders was created using secondary research, and was then used for primary research.
Primary sources include industry experts such as CEOs, vice presidents, marketing directors and other executives from companies and organizations involved in sample preparation in genomics and proteomics. All primary sources were interviewed to obtain and verify critical qualitative and quantitative information and to assess future prospects. Primary research was also done to understand segment types, industry trends and key players as well as the competitive landscape for each product. Key market dynamics such as drivers, restraints, opportunities, important issues, key player strategies and recent trends were explored.
Primary research was used to gather extensive information and to verify and validate the critical numbers derived after calculating market statistics, including market size estimations, market forecasting, market breakdown and data triangulation. Qualitative and quantitative analyses were based on secondary and primary sources. Key information obtained has been discussed throughout the report.
Neha Maliwal, a graduate in biotechnology and a postgraduate in marketing and biotechnology at the University of Pune (India), is the author of this study and numerous others, including the analyses of related markets such as antibiotics, radiopharmaceuticals, radiotherapy, healthcare business process outsourcing (BPO) and biotechnology instrumentation.